IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2017 Holdings

Filed 2017-11-14 | 18 holdings | $6.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$2.8M100,00043.0%
Adaptimmune(ADAPY)SPONDS ADR00653A107$2.0M250,00031.0%
Aurinia Pharma(AUPH)Common05156V102$1.6M252,12923.9%
Crispr(CRSP)NAMEN AKTH17182108$35.1K1,971,9070.5%
SientraCommon82621J105$33.8K2,199,0120.5%
ParatekCommon699374302$26.1K1,041,1310.4%
Cymabay(CBAYUSD)Common23257D103$12.4K1,542,7220.2%
Chiasma(CHMA)Common16706W102$5.3K2,080,5950.1%
ProteonCommon74371L109$3.9K2,017,8720.1%
CascadianCommon14740B606$3.8K925,0000.1%
Immune DesignCommon45252L103$3.6K352,3000.1%
ObsevaCommonH5861P103$3.5K440,0000.1%
GTXCommon40052B207$2.8K339,1740.0%
Ultragenyx(RARE)Common90400D108$2.0K38,1000.0%
Dermira(DERMEUR)Common24983L104$1.9K70,0000.0%
HistogenixCommon43358V109$1.8K888,8890.0%
Lombard MedicalCommonG55598109$1.5K3,473,4520.0%
Innocoll CVRCVRG4783X105$322537,2350.0%